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license (http://creativecommons.org/Summary Background/Objective: As the bone engineering field moves away from nonvi-
able implants to more biocompatible and natural structures, nanomedicine has emerged
as a superior tool for developing implantable materials.
Methods: Here, we describe the fabrication and testing of a nanocomposite structure
composed of chitosan and a biocompatible thermoplastic (PMMA).
Results: Our nanocomposite material displayed morphologically similar characteristics to an
extracted murine femur during microscopic and spectroscopic analysis as seen through SEM
and FTIR. Crosslinking our nanocomposite enhanced structural and strength characteristics
significantly above the noncrosslinked sample, mimicking the strength of an extracted
mammalian bone. When cocultured with bone marrow mesenchymal stem cells, the compos-
ite material proved to be osteoinductive and osteogenic via DAPI and actin staining, differ-
entiating BMSCs into the osteogenic lineage and promoting mineral deposition. Nodule
formation, indicative of mineralization during BMSC differentiation, was confirmed spectro-
scopically via FTIR and autofluorescence of the nodule.e Research Laboratory, Department of Medical Laboratory Sciences, College of Health Sciences, 305C
16 West Main Street, Newark, DE 19716, USA.
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106 A. Kumar et al.Conclusion: These encouraging results show promise for in vivo implantation of our novel
scaffold that is both biocompatible and biomimetic in strength and composition.
Copyright ª 2015, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open access
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Transplantable grafts are two major types: the autograft
and the allograft. Autograft transplantations occur when
tissues are transferred directly from an unaffected portion
of the patient’s body to the wounded area. Because the
tissue is from the same body, rejection risk is significantly
decreased. However, other risks, such as donor-site
morbidity, bone availability, and unpredicted graft resorp-
tion, have been associated with this procedure [1]. Allo-
grafts use tissue from an outside source, commonly a bone
bank. Because the tissue is not the patient’s own tissue,
there are higher risks of rejection. The patient’s immune
system may recognize the transplant as an antigen and
trigger a protective response [2].
Recently, synthetic bone materials have been developed
to overcome many of the obstacles listed above [3e5]. To
integrate better with the body, a synthetic bone material
must be biocompatible and accurately mimic the physical
structure of natural bone [6]. Osteoinductive and osteo-
genic potential of the material is also crucial to ensure
differentiation and proliferation of in vivo cellular net-
works [7,8]. Chitosan, a polysaccharide obtained by the
alkaline deacetylation of chitin [9], has a number of char-
acteristics that make it an adequate substance to use as a
bone replacement polymer platform, including its biode-
gradability [10], biocompatibility [11], and nontoxic nature
[12]. The structural instability of chitosan warrants
strengthening when used in chronic loading conditions
(such as femur bone synthesis) [13], so the addition of other
polymers can aid in mechanical strength [14,15].
As others have found before [16,17], the structural
instability of chitosan warrants the addition of a strength-
ening element, usually through the process of crosslinking.
Polymers, such as polyvinyl alcohol and poly-
methylmethacrylate (PMMA), both types of biocompatible
plastic [18], are often added to aid in structural stability.
Chitosan/polymer mixes for the development of skin and
organ scaffolds do not need this increased stability, but the
literature has shown [19] that without tertiary additions a
composite cannot hope to exceed the strength of a dental
cavity, let alone a femur. Our strength studies show that an
addition of 2% of 2-hydroxyethyl starch significantly aided
structural stability.
Herein, we describe the successful development of a
novel nanocomposite bone material derived from cross-
linked chitosan. We demonstrate the nanocomposite’s
favourable comparison to an extracted femur, both in
strength and morphology. Further, we establish the
biocompatibility of the nanocomposite by coculturing the
material in proximity of bone marrow-derivedmesenchymal stem cells (BMSCs), which appear to begin
osteogenic differentiation compared to cells outside the
nanocomposite’s proximity.
Materials and methods
Murine bone preparation
Animal samples were obtained from experiments that were
conducted ethically in accordance with the University of
Delaware’s Institutional Animal Care and Use Committee
guidelines for the use and care of animals (University of
Delaware, Newark, DE, USA). Mice sacrificed with CO2 had
one hind femur extracted and as much excess tissue as
possible was physically removed. The bones were more
thoroughly cleaned using a three-step wash. Briefly, bones
were soaked in chloroform for 1 minute to soften the tissue
for easier physical removal. The bone was then rinsed with
distilled water. The procedure was repeated two more
times using acetone then ethanol as the solvent. Cleaned
bones were stored at 4C.
Polymerization and preparation of nanocomposite
bone material
Chitosan (MW 100,000e300,000) was purchased from Acros
Organics (Morris Plains, NJ, USA). Chitosan need was
calculated with the following equation:
x
yþ xZ
z
100
ð1Þ
where x represents solid chitosan weight, y solvent volume,
z percentage w/v of the final solution. Once measured,
chitosan was dissolved in two beakers with a 2% acetic acid
stock solution. When the chitosan was fully dissolved, the
ground nanocomposite bone material was added to each
beaker and homogenized. The resulting substance was left
to dry on an Isotemp hotplate (Fisher Scientific, Waltham,
MA, USA) set at 55C.
Two percent w/v PMMA (Acros Organics) was added to
the sample for structural stability. An appropriate amount
PMMA was dissolved in chloroform. The dried chitosan
sample was ground up and added to the beaker with the
dissolved PMMA. Two percent w/v 2-hydroxyethyl starch
(Spectrum Chemical, Gardena, CA, USA) was added using
the same process as PMMA, except warm water was used as
a solvent rather than chloroform. The resulting substance
was left to dry overnight.
A rectangular prism shape was formed from the sample
in order to allow for physical experimentation. When the
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removed from the beaker and placed onto a sheet of foil,
where it was manually shaped into a rectangular prism of
approximate size 10 mm  3 mm  4 mm. It was then
allowed to dry on a hotplate set to 60C.
Fourier transformed infrared spectroscopy
A Nicolet iS5 spectrometer with an iD5 ATR diamond tip
adapter (Thermo Scientific, Waltham, MA, USA) was used to
perform Fourier transformed infrared spectroscopy (FTIR).
The samples were ground and dissolved in their respective
solvents, and 10 mL was placed at the diamond tip/sample
interface. Samples were measured to determine charac-
teristic peaks relating to bond stretching and rocking, using
the respective solvents as a blank. The FTIR analysis was
carried out over a wave number range between 4000 cm1
and 400 cm1 at a resolution of 2 cm1.
Scanning electron microscopy analysis
Scanning electron microscopy (SEM) was performed to
visualize the mammal bone sample and two 6% chitosan
samples. The four samples were sliced with a microtome
and mounted on aluminium mount-M4 sample holders
(Electron Microscopy Sciences, Hatfield, PA, USA) and
placed in a Denton Bench Top Turbo III vacuum chamber
(Denton Vacuum, Moorestown, NJ, USA) for coating with a
50:50 mix Au:Pd to aid visualization. The samples were
placed into the microscope (S4700; Hitachi High Technolo-
gies, Tokyo, Japan) and images were taken from 1800 to
15,000 magnification.
Three-point analysis
Three-point analysis was performed on an RSA G2 solids
analyser (Texas Instruments, Dallas, TX, USA). Samples
measuring 10 mm  3 mm  4 mm were placed on two
bottom pressure points that doubled as support structures.
A computer recorded a third shaft’s force applied to the
sample at 0.4 N/s and displacement Z-height of said shaft
calculated as distance from Point 0 (top of the sample)
moving at approximately 8.75 mm/s.
Cell culture
A composite bone material of approximate dimensions
3 mm  4 mm  3 mm was placed in a 10 cm2 petri dish. To
sterilize, the composite material was left in the open dish
in the culture hood under UV light for 1 hour. BMSCs
(StemCell Technologies, Vancouver, BC, Canada) were
plated around the composite material at a density of
3  105 cells/mL, and 3e4 mL of noncomplete MesenCult
basal media (StemCell Technologies) was added. Cells were
incubated at 37C and 5% CO2 for 3 days in a Forma Steri-
Cycle CO2 Incubator (Thermo Scientific) with images
taken every 24 hours. At the end of 72 hours, the media and
composite material were removed from the culture. Cells
were fixed in 4% paraformaldehyde in phosphate buffered
saline (PBS) for 10 minutes and washed three times for 3
minutes each in PBS. ActinRed 555 and NucBlue MolecularProbes stains (Life Technologies, Carlsbad, CA, USA) were
prepared in PBS as per company specifications and incu-
bated on cells for 20 minutes. Cultures were then washed in
PBS three times for 3 minutes and imaged using an Evos FL
fluorescence microscope (Thermo Scientific).
Statistical analysis
The statistical significance of the results was determined
using analysis of variance (ANOVA) and a multiple means
comparison function (t test) in JMP (SAS Institute Inc., Cary,
NC, USA) with an a level of 0.05. All error bars are reported
in mean  standard error from the mean, with nZ 3 unless
otherwise noted.
Results
Sample construction
Concentrations of chitosan samples of 2%, 4%, 6%, and
8% w/v were developed and assessed for structural stabil-
ity. The 2% and 4% samples crumbled immediately upon
contact with the instruments, and purity and ease of use
issues dissuaded use of the 8% samples.
Polyvinyl alcohol and PMMA, both types of biocompatible
plastic, were added to dissolved 6% w/v chitosan samples to
increase sample stability further. PMMA yielded a more
useable product, so 2% w/v PMMA was added to the 6% w/v
chitosan sample used in further analysis. Lastly, 2% w/v of
2-hydroxyethyl starch was dissolved into the PMMA/chito-
san sample to finalize the structural stability.
Fig. 1 demonstrates the chemical synthesis used to
formulate the nanocomposite bone sample. The final sam-
ples were shaped as described in the Methods section and
imaged using SEM (Fig. 2). Molecular purity and chemical
similarity to bone was confirmed via FTIR (Fig. 1B).
SEM analysis
While the 6% chitosan sample was most durable, it still
needed to be compared to the native mammalian bone
Fig. 2. As shown, the 6% crosslinked sample had a much more
even texture than the noncrosslinked chitosan samples. Even
when zoomed to 15,000, this characteristic description
stays accurate, and is similarly textured to the mammalian
bone. This texture similarity would translate directly to
improved tensile strength and osteoinductive potential [3].
Three-point analysis results
Samples were placed onto the two bottom pressure points
while a third shaft applied force to the middle of the sam-
ple. The noncrosslinked nanocomposite sample withstood
an average of 1.4N of downwards force before beginning to
crack, eventually bending to such an extreme that the
experiment was manually ended (Fig. 3A). The crosslinked
nanocomposite withstood a significantly greater amount of
force than the noncrosslinked sample, and compared much
more favourably to the actual mammalian bone sample
(Fig. 3B and C). The average breaking point occurred when
Figure 1 (A) Chemical synthesis of crosslinked nanocomposite material resulting in a morphologically desirable nanocomposite
material. (a) A chitosan starting material (blue) was dissolved in acetic acid and combined with a dissolved poly-
methylmethacrylate (PMMA; green) mixture in chloroform to form a slurry. 2-Hydroxyethyl starch (red) dissolved in heated water
was then combined with the slurry. (b) Magnified 6% chitosan nanocomposite sample. The porous nature of the sample provides
ample room for nutrient passage and waste disposal. Scale bar 1 mm; 35,000 magnification. (B) Fourier transformed infrared
spectroscopy analysis of the mammalian bone sample and the crosslinked nanocomposite. (a) Nanocomposite sample showing
characteristic peaks of the three contributing elements: chitosan, starch, and PMMA. Amine peaks from chitosan can be seen at
3500e3300 cm1, ester contributions from PMMA can be observed at 1750e1735 cm1, and alcohol, alkyl, and ether peaks that are
present in all samples can be seen at 3550e3200 cm1, 2950e2850 cm1, and 1250e1030 cm1. (b) Mammalian bone sample.
Carbonate-to-phosphate ratio areas can be seen at 850e890 cm1, crystallinity peak areas can be seen at 1000e1100 cm1, and
mineral-to-matrix ratios can be seen at 900e1200 cm1. (For interpretation of the references to colour in this figure legend, the
reader is referred to the web version of this article.)
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Figure 2 Scanning electron microscope images of the mammal bone and nanocomposite samples. (A) Mammal bone. Scale bar
5 mm; 8000magnification. (B) 6% chitosan sample, not crosslinked. Note the random indentations and uneven protrusions from the
surface, producing a coarse sample. Scale bar 20 mm; 1800 magnification. (C) 6% chitosan sample, crosslinked. The structural
surface homogeneity is very similar to the natural mammal bone. Scale bar 3 mm; 15,000 magnification.
Figure 3 Three-point analysis tests of nanocomposite and murine samples. (A) Representative noncrosslinked nanocomposite
sample. The experiment was ended because the sample deformed beyond analysis. (B) Representative crosslinked nanocomposite
samples and (C) representative mammalian femur samples withstood a much greater force application before breakage, producing
curves indicative of standard force/displacement graphs. (D) Force comparisons across multiple samples. There was no significant
difference in average force before breakage between the mammalian femur and the crosslinked sample (p Z 0.228). Both the
mammalian femur and crosslinked samples were significantly stronger than the noncrosslinked nanocomposite sample. N Z 3.
*p < 0.002 via analysis of variance and t test. NS Z not statistically significant.
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Figure 4 Bone marrow mesenchymal stem cell (BMSC) differentiation over a 72-hour culture period. (A) BMSCs were imaged 2
hours after seeding to show gap zone between nanocomposite material (labeled NC) and seeded BMSCs, approximately 2 mm.
Arrows indicate hypothesized direction of stem cell migration. Scale bar 1000 mm; magnification 4. (B) 10 magnification of the
direct culture after 2 hours. All cells have adhered to the culture dish surface but have not begun to proliferate. Scale bar 200 mm.
(CeE) Cells 24 hours, 48 hours, and 72 hours, respectively, after seeding. Notice how cells have migrated past the gap zone towards
the composite material (labeled NC). Mineralization produced by differentiated cells are indicated by white arrowheads. In (E), the
circled area is the focus of Fig. 5. Scale bar 1000 mm; magnification 4. (FeH) Cells on the fringe of the culture area 24 hours, 48
hours, and 72 hours, respectively, after seeding. Note the lack of mineralization and differentiation of cells. (H) Dark spot on
bottom right is due to camera error, not mineralization. Scale bar 1000 mm; magnification 4. (I) Boundary region observed be-
tween cells differentiated due to the bone composite versus those due to culture conditions. Tan arrows indicate cell morphology
differences; white arrows point to floating composite material dissolved off of the main block; blue arrows indicate boundary line.
Scale bar 200 mm; magnification 10. (For interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article.)
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downwards force of 18.6N. The mouse femur control had an
average breaking point when there was a downwards
displacement of 0.47 mm and a downwards force of 20.07N
(Fig. 3C). No statistical difference was observed between
the crosslinked sample and the mammalian bone
(p Z 0.228), but both samples were significantly stronger
than the noncrosslinked nanocomposite (p < 0.002; Fig. 3D).
Biocompatibility
To be an ideal in vivo material, an engineered bone com-
posite must be biocompatible. We sought to determinewhether the developed composite material was able to be
successfully cocultured with BMSCs, proving biocompati-
bility, and whether the nanocomposite had any influence on
BMSC differentiation. BMSCs were seeded approximately
2 mm from the crosslinked composite material (Fig. 4A) and
incubated for 72 hours. After 24 hours, perceived miner-
alization was readily apparent around the composite ma-
terial (Fig. 4C) compared to cells growing along the fringe
elements away from the composite (Fig. 4F). The compos-
ite material stimulated cell migration towards itself,
prompting increased differentiation and mineralization as
the cells came in closer proximity to the nanocomposite
(Fig. 4CeE). Neither the composite material nor the culture
Figure 5 Analysis of culture 72 hours postseed. (AeE) Cells and mineralization from an area adjacent to bone composite (see
circled portion in Fig. 4E). (FeJ) Cells on the fringe of the culture dish with little to no contact with bone composite material. (A, F)
Light microscope; (B, G) DAPI filter of NucBlue stain; (C, H) 470 nm/525 nm filter of autofluorescence of bone composite material
surrounding cells and embedded in the mineralised component; (D, I) 531nm/593nm filter of ActinRed 555 stain; (E, J) overlay of
autofluorescence and stains. (K) Fourier transformed infrared spectra of one bone nodule produced by bone marrow-derived
mesenchymal stem cell culture. Peaks indicative of phosphate-to-carbonate ratio area and cortical bone similarities are high-
lighted. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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was seen around the composite (Fig. 4CeE) and in the un-
treated portions of the dish (Fig. 4FeH). Interestingly, a
differentiation boundary was observed after 48 hours
(Fig. 4I). As deemed by DAPI filters and autofluorescence,
this boundary was formed from dissolved composite mate-
rial and spread out in a halo around the composite (data not
shown). The conditions within and beyond this boundary
were profoundly different, changing cell morphology and
culture viscosity (Fig. 4I, arrows).
After 72 hours, the media was removed and the cells
were fixed and stained as described in the Methods sec-
tion. Two contrasting culture areas were imaged (Fig. 5):
an area of high cell growth and biomaterial deposition
(highlighted in Fig. 4E; analysed in Fig. 5AeE) was
compared to a fringe portion of the culture several cen-
timetres from the composite bone (Fig. 5FeJ). The
mineralization area showed increased cell density and
differentiation (Fig. 5A and B), with increased F-actin
production indicative of immature osteogenic differenti-
ation to osteoblasts (Fig. 5D) [20]. By contrast, cells on
the periphery of the culture on the opposite side of the
differentiation boundary, showed limited cellular hyper-
trophy and proliferation (Fig. 5F and G), and only the
requisite amount of b-actin to maintain cellular
morphology (Fig. 5I). The high cell growth and deposition
area also showed an autofluorescence when observed
under the 470 nm excitation/525 nm emission filter of the
Evos FL (Fig. 5C), and the fringe area showed little to no
autofluorescence (Fig. 5H). When examined under FTIR,
the deposition material produced a spectra almost iden-
tical to young cortical bone (Fig. 5K; Rhonda Prisby and
Arun Kumar, unpublished data), potentially indicating the
beginnings of bone formation in vitro.Discussion
The role of nanomedicine in biomedical and tissue engi-
neering applications is becoming increasingly apparent with
the advent of more biocompatible structures that aid in cell
growth and stem cell differentiation. However, issues may
arise when developing structures that will implant to a
system with disproportionately large loading forces, such as
the femur bone.
Analysis of the SEM images brought results suggesting
that the crosslinked 6% chitosan sample more closely re-
sembles the texture of the mammal bone. This is pertinent
to the final goal because, as previously shown [21], texture
plays a key role in osteoblast adherence and proliferation
to bone composites. The more porous nature of the nano-
composite (Fig. 2B) will allow nutrient and waste exchange
with the outside environment, allowing full thickness
seeding of the composite material. This will assist in
quicker cell growth and promote the native bone to over-
take the nanocomposite. The porous nature will also
require little biodegradation before vasculature can
permeate the sample, which is crucial, as angiogenesis is
the key to promoting efficient bone growth [22].Perhaps the most important aspect of any graft of
composite bone material is its ability to withstand the
forces applied by the human body during day-to-day ac-
tivities. While pressure on bones significantly varies
depending on the level and type of activity [23], the femur
is an ideal model as it is both the strongest and longest bone
in any mammalian system [24,25]. Therefore, any com-
posite material that can withstand three-point analysis
testing comparative to a femur sample would theoretically
be able to be scaled back in vitro in order to realistically
match and support more pliable bones. Indeed, our cross-
linked sample was more flexible than our mammal bone
control (as seen by the extent of shaft displacement), a
desirable characteristic that will allow more flexibility
in vivo. The flexibility would be worrisome if it came at the
expense of strength, but the analysis showed no difference
in the crosslinked sample compared to the mammalian
bone. As is, the crosslinked nanocomposite sample is
comparable to other studies using femurs and ulnas [26].
Since bone mineral density and strength decrease with age
[27], the composite material could theoretically be suc-
cessfully used in repair of fractures in the elderly. The
Young’s modulus of the crosslinked sample was also not
significantly different from the mammalian bone (data not
shown). While the current nanocomposite and mammalian
femur demonstrated Young’s moduli of the order of tenths
of a GPa, scaling up the material to the size of a human
cortical or trabecular bone would presumably allow for
Young’s modulus values to reach the requisite 14e20 GPa
needed for full support [28].
The boundary area during cell culture was a surprising
development in the analysis. While it was hypothesized
that the cells would migrate towards the biocompatible
bone composite and begin to differentiate, the effects of
the nanocomposite were expected to dissipate in a con-
centration dependent manner, not at an abrupt line. This
is a beneficial addition to future data, as the size of this
boundary region could be controlled to develop a micro-
environment around the nanocomposite in vivo that would
control the extent of osteoinduction and eliminate any
system-wide effects. Our results show that there is po-
tential for osteoinduction based on F-actin staining [20],
but further molecular analysis is needed before claims of
osteoinduction of BMSCs can be verified. The auto-
fluorescence of the nanocomposite material was observed
prior to staining (data not shown), and was used as a
marker to show interactions between the cell material and
the dissolved nanocomposite (Fig. 5C). Also surprising was
the autofluorescence under the 470 nm/525 nm filter after
washing and fixing. We hypothesise that the nano-
composite dissolved into solution (as shown by the
boundary region) and bound to the cells through a re-
ceptor, such as the a1b1 integrin, that has been previously
shown to steer stem cells down the osteogenic pathway
[29]. The attachment of the nanocomposite material to
the BMSCs/osteoblasts shows a very high dissociation
constant and avidity of the material to the receptors, as
indicated by time-in-culture analysis and adherence
following fixation and staining. The elucidation of the
respective receptors on the BMSCs (and ultimately
Nanocomposite biomaterial to differentiate BMSCs 113osteoblasts) could lead to a new drug target to promote
osteogensis in osteoporotic individuals.
Conclusion
The goal of this study was to develop a nanocomposite
material that compared favourably to an actual mammalian
bone sample. We successfully developed two samples: a
noncrosslinked and a crosslinked 6% chitosan/2% PMMA/2%
starch sample. The crosslinked sample was superior to the
noncrosslinked sample in strength, chemical, and micro-
scopic analysis. When deposited next to cultures of BMSCs,
the nanocomposite material showed biocompatible ten-
dencies by promoting migration and proliferation of BMSCs.
Mineralized nodule deposits into culture by the differenti-
ated BMSCs showed spectroscopically similar results to
extracted mammalian cortical bone, indicating new bone
formation. Future genetic and molecular analysis, such as
alkaline phosphatase activity and polymerase chain reac-
tion, will determine whether cellular deposition is indica-
tive of osteogenic differentiation, proving that the
nanocomposite is also osteoinductive.
Conflicts of interest
The authors declare no competing financial interests.
Funding/support
Dr. Kumar would like to acknowledge the startup funding
and UDRF (University of Delaware Research Foundation)
Award he received from the University of Delaware.
References
[1] Messora MR, Nagata MJ, Pola NM, de Campos N, Fucini SE,
Furlaneto FA. Effect of platelet-rich plasma on bone healing of
fresh frozen bones allograft in mandibular defects: a histo-
morphometric study in dogs. Clin Oral Implants Res 2012;24:
1347e53.
[2] Colvin RB, Smith RN. Antibody-mediated organ-allograft
rejection. Nature Rev Immunol 2005;5:807e17.
[3] Lo KWH, Ulery BD, Ashe KM, Laurencin CT. Studies of bone
morphogenetic protein based surgical repair. Adv Drug Deliv
Rev 2012;64:1277e91.
[4] Evans CH. Gene delivery to bone. Adv Drug Deliv Rev 2012;64:
1331e40.
[5] Demers C, Hamdy CR, Corsi K, Chellat F, Tabrizian M, Yahia L.
Natural coral exoskeleton as a bone graft substitute: a review.
Biomed Mater Eng 2002;12:15e35.
[6] Lee MJ, Sohn SK, Kim KT, Kim CH, Ahn HB, Rho MS, et al. Effect
of hydroxyapatite on bone integration in a rabbit tibial defect
model. Clin Orthop Surg 2010;2:90e7.
[7] Spalazzi JP, Doty SB, Moffat KL, Levine WN, Lu HH. Develop-
ment of controlled matrix heterogeneity on a triphasic scaf-
fold for orthopedic interface tissue engineering. Tissue Eng
2006;12:3497e508.
[8] Moore WR, Graves SE, Bain GI. Synthetic bone graft sub-
stitutes. ANZ J Surg 2001;71:354e61.
[9] Albrektsson T, Johansson C. Osteoinduction, osteoconduction
and osseointegration. Eur Spine J 2001;10:S96e101.[10] Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic
differentiation of purified, culture-expanded human mesen-
chymal stem cells in vitro. J Cell Biochem 1997;64:295e312.
[11] Morgado J, Pereira AT, Braganc¸a AM, Ferreira Q,
Fernandes SCM, Freire CSR, et al. Self-standing chitosan films
as dielectrics in organic thin-film transistors. Express Polym
Lett 2013;7:960e5.
[12] Hu Q, Li B, Wang M, Shen J. Preparation and characterization
of biodegradable chitosan/hydroxyapatite nanocomposite
rods via in situ hybridization: a potential material as internal
fixation of bone fracture. Biomaterials 2004;25:779e85.
[13] Struszczyk H, Wawro D, Niekraszewicz A. Advances in chitin
and chitosan. London: Elsevier Applied Science; 1991.
[14] Illum L. Chitosan and its use as a pharmaceutical excipient.
Pharm Res 1998;15:1326e31.
[15] Dai T, Tanaka M, Huang YY, Hamblin MR. Chitosan preparations
for wounds and burns: antimicrobial and wound-healing ef-
fects. Expert Rev Anti Infect Ther 2011;9:857e79.
[16] Lee JW, Kim SY, Kim SS, Lee YM, Lee KH, Lee SJ. Synthesis and
characteristics of interpenetrating polymer network hydrogel
composed of chitosan and poly(acrylic acid). J Appl Polym Sci
1999;73:113e20.
[17] Su N, Chen M, Chen S, Li C, Xie Y, Zhu Y, et al. Overexpression
of H1 calponin in osteoblast lineage cells leads to a decrease
in bone mass by disrupting osteoblast function and promoting
osteoclast formation. J Bone Miner Res 2013;28:660e71.
[18] Wang TJ, Wang IJ, Lu JN, Young TH. Novel chitosan-
polycaprolactone blends as potential scaffold and carrier for
corneal endothelial transplantation. Mol Vis 2012;18:255e64.
[19] Bhat S, Tripathi A, Kumar A. Supermacroprous chito-
saneagaroseegelatin cryogels: in vitro characterization and
in vivo assessment for cartilage tissue engineering. J R Soc
Interface 2011;8:540e54.
[20] Ashori A, Cordeiro N, Faria M, Hamzeh Y. Effect of chitosan
and cationic starch on the surface chemistry properties of
bagasse paper. Int J Biol Macromol 2013;58:343e8.
[21] Tsao CW, Hromada L, Liu J, Kumar P, DeVoe DL. Low tem-
perature bonding of PMMA and COC microfluidic substrates
using UV/ozone surface treatment. Lab Chip 2007;7:499e505.
[22] Flores-Ramı´rez N, Luna-Ba´rcenas G, Va´squez-Garcı´a SR,
Mun˜oz-Saldan˜a J, Elizalde-Pen˜a EA, Gupta RB, et al. Hybrid
natural-synthetic chitosan resin: thermal and mechanical
behavior. J Biomat Sci Polym Ed 2008;19:259e73.
[23] Costa-Pinto AR, Reis RL, Neves NM. Scaffolds based bone tis-
sue engineering: the role of chitosan. Tissue Eng Part B Rev
2011;17:331e47.
[24] Towler DA. The osteogenic-angiogenic interface: novel in-
sights into the biology of bone formation and fracture repair.
Curr Osteoporos Rep 2008;6:67e71.
[25] Kohrt WM, Barry DW, Schwartz RS. Muscle forces or gravity:
what predominates mechanical loading on bone? Med Sci
Sports Exerc 2009;41:2050e5.
[26] Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J,
Ensrud K, et al. Bone density at various sites for prediction of
hip fractures. The Study of Osteoporotic Fractures Research
Group. Lancet 1993;341:72e5.
[27] Silva MJ, Brodt MD, Lynch MA, McKenzie JA, Tanouye KM,
Nyman JS, et al. Type 1 diabetes in young rats leads to pro-
gressive trabecular bone loss, cessation of cortical bone
growth, and diminished whole bone strength and fatigue life.
J Bone Miner Res 2009;24:1618e27.
[28] Boskey AL, Coleman R. Aging and bone. J Dent Res 2010;89:
1333e48.
[29] Rosa AL, Kato RB, Castro Raucci LM, Teixeira LN, de
Oliveira FS, Bellesini LS, et al. Nanotopography drives stem
cell fate toward osteoblast differentiation through a1b1
integrin signaling pathway. J Cell Biochem 2014;115:540e8.
